RetinGuard®
60 enteric coated capsules

Some of the most exciting research related to maintaining optimal vision has been in the area of nutrition. Studies have provided evidence that supplementation with lutein and zeaxanthin is associated with significant improvement in the density of the protective macular pigment.* The macula is the portion of the retina that is responsible for our central vision, which is essential for activities such as driving and reading.

Lutein and zeaxanthin belong to a class of carotenoids known as xanthophylls, which are typically found in leafy green vegetables, many fruits, and colored vegetables such as squash, sweet peppers, sweet corn, and peas. These two carotenoids are the main components of the macula’s luteal pigment that protects the retina by absorbing damaging light and neutralizing free radicals. Now, new research indicates a third carotenoid, meso-zeaxanthin may be needed for complete macular density protection.* Scientists believe meso-zeaxanthin can provide better protection against lipid membrane oxidation than lutein and zeaxanthin.*

RetinGuard® is a state-of-the-art formula that combines lutein, zeaxanthin and meso-zeaxanthin along with additional nutrients to maintain healthy macular function.* RetinGuard® is the result of extensive analysis of the medical literature to date and represents VitalRemedyMD’s desire to provide the safest and most scientifically validated nutrients for promoting healthy vision.*

Supplement Facts

Serving Size 2 enteric coated capsules
Servings Per Container 30

Amount Per Serving
Vitamin C (as ascorbic acid).............................................500 mg 833%
Vitamin E (as d-Alpha Tocopheryl Acetate 
and Natural Mixed Tocopherols)..........100 IU 333%
Vitamin B2 (riboflavin)..................................................3.4 mg 200%
Zinc (as zinc amino acid chelate)..............................................25 mg 167%
Copper (as copper amino acid chelate).............................................1 mg 50%
N-acetyl-cysteine (NAC)..................................................100 mg
Lutein (as Lutein PLUS)...................................................10 mg
Zeaxanthin (as Lutein PLUS)................................................4 mg
Meso-zeaxanthin (as Lutein PLUS)...........................................6 mg
Other ingredients:Rice Flour Powder, Gelatin, Magnesium Stearate, Silicon Dioxide, Methacrylic Triacetin, FCC; Vanilla Flavor.

This product contains NO milk, egg, fish, peanuts, crustacean shellfish, soybeans, tree nuts, wheat, yeast, or gluten. Contains NO sugar, and no artificial sweeteners, flavors, colors, or preservatives. Although manufacturing equipment is thoroughly cleansed after all production runs, this product is manufactured in a facility that utilizes milk, egg, fish, peanuts, crustacean shellfish, soybeans, tree nuts, wheat, yeast, and gluten.

Directions: Take two (2) enteric coated capsules daily with food, or as directed by your physician.

References

Age-Related Eye Disease Study Research Group. The Relationship of Dietary Carotenoid and Vitamin A, E, and C Intake With Age-Related Macular Degeneration in a Case-Control Study: AREDS Report No. 22. Arch Ophthalmol. 2007 Sep;125(9):1225-32.

Bone RA, Landrum JT, Guerra L H., Ruiz CA. Lutein and Zeaxanthin Dietary Supplements Raise Macular Pigment Density and Serum concentration of these Carotenoids. J Nutr. 2003;133:992–998.

Landrum JT, Bone RA, Joa H, Kilburn MD, Moore LL, Sprague KE. A One Year Study of the Macular Pigment: The Effect of 140 Days of a Lutein Supplement. Exp Eye Res. 1997;65:57–62.

Bone RA, Landrum JT, Hime GW, Cains A, Zamor J. Stereochemistry of the Human Macular Carotenoids. Invest Ophthalmol Vis Sci. 1993;34:2033–2040.

Bone RA, Landrum JT, Fernandez L, Tarsis SL. Analysis of the Macular Pigment by HPLC: Retinal Distribution and Age Study. Invest Ophthalmol Vis Sci.. 1988;29:843–849.

Handelman GJ, Dratz EA, Reay CC, van Kuijk FJGM. Carotenoids in the human macula and whole retina. Invest Ophthalmol Vis Sci. 1988;29:850–855.

Bone RA, Landrum JT, Tarsis SL. Preliminary Identification of the Human Macular Pigment. Vision Res. 1985;25:1531–1535.

Beatty S, Koh HH, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2000;45:115–134.

Bone RA, Landrum JT, Cao Y, et al. Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin. Nutr Metab (Lond). 2007 May 11;4:12.

Bhosale P, Bernstein PS. Synergistic effects of zeaxanthin and its binding protein in the prevention of lipid membrane oxidation. Biochim Biophys Acta. 2005;1740:116–121.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.